A recent study indicates that patients who stop using blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight far faster than those who end traditional lifestyle programs.
Research printed in a major health publication points out that while obese people often shed about a fifth of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month once they quit.
"Individuals purchasing such medications should be aware of the danger of rapid weight regain when the medication ends," stated researcher Dr. Susan Jebb.
This pace of recovery implies a return to original mass within about a year and a half.
Analyzing Therapies
The research, which reviewed dozens of studies involving over 9,000 of participants, compared the results of GLP-1 agonists with older methods.
Researchers note that individuals who lose weight through diet and exercise typically experience a more gradual creep back—perhaps 100 grams monthly—once they finish.
The Reason for the Fast Regain
Doctors suggest the way of the jabs is key to understanding the amplified weight return.
These medications mimic a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of the hormone concentrations far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication results in hunger is unsuppressed, making overeating a significant risk."
A Chronic Condition?
Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians say that, due to the significant potential of relapse, the treatment is often life-long.
This opinion is supported by pharmaceutical companies, who say that the results "underscore the long-term nature of obesity," comparing it to managing conditions like high blood pressure.
User Accounts
Individuals who have come off the medication explain a intense resurgence of appetite.
"It felt as if a switch that goes on and I was suddenly ravenous," recalled one woman.
This challenge is worsened if individuals have not established sustainable dietary or behavioural changes during treatment.
Widespread Use
Survey data suggest that millions of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Adoption is greater among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while the jabs are powerful tools for shedding pounds, they are not a magic cure and lasting health benefits likely depends on combined behavioural support.